Search filters

List of works by Anna Durbin

A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response

scientific article

A Dengue Vaccine

scientific article published on June 2016

A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Δ30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers

scientific article

A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals

scientific article published on 15 May 2009

A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial ⬇️

scientific article published on August 2, 2011

A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus ⬇️

scientific article

A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial

scientific article published on 17 January 2013

Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali

scientific article

An update on Zika vaccine developments

scientific article published on 21 June 2017

Antibody responses to Zika virus infections in flavivirus-endemic environments

scientific article (publication date: 22 February 2017)

Antigenic relationships between sylvatic and endemic dengue viruses.

scientific article

Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines.

scientific article

Building Bridges to Housing for homeless adults with intellectual and developmental disabilities: outcomes of a cross-sector intervention

scientific article published on 26 July 2020

Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines

scientific article published on 7 March 2018

Comparing the understanding of subjects receiving a candidate malaria vaccine in the United States and Mali

scientific article

Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies

scientific article published on 13 May 2015

Cross-reactive antibodies facilitate innate sensing of dengue and Zika viruses

scientific article published in 2022

Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus-Specific CD8 T Cells

article

Decay and persistence of maternal dengue antibodies among infants in Bangkok

scientific article published on August 2011

Dengue Antibody and Zika: Friend or Foe?

scientific article (publication date: October 2016)

Dengue Human Infection Models to Advance Dengue Vaccine Development

scientific article published on 21 October 2015

Dengue human infection models to advance dengue vaccine development

scientific article published on 27 September 2015

Dengue vaccine candidates in development

scientific article published on January 2010

Dengue viruses cluster antigenically but not as discrete serotypes

scientific article published on September 2015

Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine ⬇️

scientific article published on July 21, 2011

Development of a live attenuated dengue virus vaccine using reverse genetics

scientific article

Early Transcriptional Responses After Dengue Vaccination Mirror the Response to Natural Infection and Predict Neutralizing Antibody Titers

article

Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity

scientific article published on 26 February 2013

Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers

scientific article

Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization

scientific article published on 01 October 2018

Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas

scientific article published on 13 October 2017

HIV-1 evolution following transmission to an HLA-B*5801-positive patient

scientific article published on December 2009

Heterotypic Dengue Infection with Live Attenuated Monotypic Dengue Virus Vaccines: Implications for Vaccination of Populations in Areas Where Dengue Is Endemic ⬇️

scientific article published on December 14, 2010

Human CD4+ T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection, in magnitude, HLA restriction and antigen specificity

scientific article (publication date: 14 December 2016)

Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes.

scientific article

Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics

scientific article published on 22 March 2013

In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination

scientific article (publication date: May 2017)

Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation

scientific article published on 06 April 2013

Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model

article

Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination

scientific article (publication date: 28 December 2016)

Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization

scientific article (publication date: 9 May 2008)

Mechanism and significance of cell type-dependent neutralization of flaviviruses

scientific article

Monitoring adverse events following yellow fever vaccination using an integrated telephone and Internet-based system

scientific article published on 25 August 2009

New chapter unfolding in the fight against dengue with an unwritten ending

scientific article published in October 2014

Next-Generation Dengue Vaccines: Novel Strategies Currently Under Development ⬇️

scientific article published on September 26, 2011

Patterns of cellular immunity associated with experimental infection with rDEN2Δ30 (Tonga/74) supports its suitability as a human DENV challenge strain

scientific article (publication date: February 2017)

Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4 30-4995 in Healthy Adult Volunteers

scientific article (publication date: November 2009)

Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria

scientific article

Phase 1 study in malaria naïve adults of BSAM2/Alhydrogel®+CPG 7909, a blood stage vaccine against P. falciparum malaria

scientific article

Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.

scientific article

Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in malaria naïve adults

scientific article (publication date: 22 January 2010)

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria

scientific article published in May 2005

Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity

scientific article

Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever

scientific article

Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response

scientific article published on 03 May 2019

Primary vaccination with low dose live dengue 1 virus generates a proinflammatory, multifunctional T cell response in humans

scientific article

Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans

scientific article published on 4 October 2017

Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines

scientific article

Rapid changes in serum cytokines and chemokines in response to inactivated influenza vaccination

scientific article published on 9 October 2017

Report of an NIAID workshop on dengue animal models

scientific article

Response to Ruiz-Alejo et al.

scientific article published on 11 July 2013

Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge

scientific article published on 22 March 2006

Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults

scientific article

Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults

scientific article

Status of vaccine research and development of vaccines for dengue

scientific article published on 10 March 2016

Systemic pharmacokinetics of rifaximin in volunteers with shigellosis

scientific article

Targeted mutagenesis as a rational approach to dengue virus vaccine development

scientific article

The Dengue Human Challenge Model: Has the Time Come to Accept This Challenge? ⬇️

scientific article published on December 5, 2012

The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals

scientific article

The dengue vaccine pipeline: Implications for the future of dengue control

scientific article

The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes

scientific article

The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers

scientific article published on 19 August 2013

The live attenuated dengue serotype 1 vaccine rDEN1Delta30 is safe and highly immunogenic in healthy adult volunteers.

scientific article published on 24 July 2006

The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model

scientific article

The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein

scientific article

Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4.

scientific article published on 7 December 2017

Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profiles

scientific article published on 02 June 2013

Vaccine Development for Zika Virus-Timelines and Strategies

scientific article published on 8 September 2016

Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis

scientific article

Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data

scientific article

Zika Vaccines: Role for Controlled Human Infection

scientific article published in December 2017

Zika vaccines and therapeutics: landscape analysis and challenges ahead.

scientific article published on 6 June 2018

rDEN2/4Delta30(ME), a live attenuated chimeric dengue serotype 2 vaccine is safe and highly immunogenic in healthy dengue-naïve adults.

scientific article published on 5 November 2006

rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers

scientific article published on 27 January 2005

Paulina is supported by:

About Paulina

Help